Oxaliplatin Causes Transient Changes in TRPM8 Channel Activity
Oxaliplatin is a third-generation platinum-based anticancer drug that is widely used as first-line treatment for colorectal carcinoma. Patients treated with oxaliplatin develop an acute peripheral pain several hours after treatment, mostly characterized by cold allodynia as well as a long-term chron...
Main Authors: | Vittoria Rimola, Tabea Osthues, Vanessa Königs, Gerd Geißlinger, Marco Sisignano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/9/4962 |
Similar Items
-
Characterization of New TRPM8 Modulators in Pain Perception
by: Carmen De Caro, et al.
Published: (2019-11-01) -
Involvement of TRPM2 in a wide range of inflammatory and neuropathic pain mouse models
by: Kanako So, et al.
Published: (2015-03-01) -
Oxaliplatin Depolarizes the IB4– Dorsal Root Ganglion Neurons to Drive the Development of Neuropathic Pain Through TRPM8 in Mice
by: Bin Wu, et al.
Published: (2021-06-01) -
Topical TRPM8 Agonist for Relieving Neuropathic Ocular Pain in Patients with Dry Eye: A Pilot Study
by: Hyeon Jeong Yoon, et al.
Published: (2021-01-01) -
Effect of Oxaliplatin on Voltage-Gated Sodium Channels in Peripheral Neuropathic Pain
by: Woojin Kim
Published: (2020-06-01)